CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Exhibits
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $3.96 ($39,600)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 400,000 shares at $4.04 ($1,616,000)
- 4 Open-market sale Director sold 10 shares at $4.50 ($45)
- 4 Open-market sale Director sold 191,865 shares at an average $4.59 ($879,719)
- 4 Open-market sale Chief Scientific Officer sold 1,738 shares at $4.76 ($8,273)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
Page 1 of 10 · 193 filings